Clinical Trial Update: Casodex - Nolvadex Combination [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of Casodex (bicalutamide) and Nolvadex (tamoxifen) for prostate cancer and gynecomastia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecomastia
• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)
• Nolvadex (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Gynaecomastia, Prostate Cancer | Phase 2 | Status: COMPLETED